Convergence of schiff base costimulatory signaling and TCR signaling at the level of mitogen-activated protein kinase ERK2

Journal of Immunology

Volumn 159, Issue 5, 1997, Pages 2274-2281

  Chen, Huaqing ^a   Hall, Simon ^a   Heffernan, Brian ^a   Thompson, Neil T ^a   Rogers, Mark V ^a   Rhodes, John ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BENZALDEHYDE DERIVATIVE; BENZOIC ACID DERIVATIVE; BORANE DERIVATIVE; CALCIUM; ENZYME INHIBITOR; FLAVONOID; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; MAP2K1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; OKT 3; POTASSIUM; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SCHIFF BASE; SODIUM; SODIUM BOROHYDRIDE; TUCARESOL;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TRANSPORT AT THE CELLULAR LEVEL;

BENZALDEHYDES; BENZOATES; BIOLOGICAL TRANSPORT; BOROHYDRIDES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; INTERLEUKIN-2; LEUKEMIA, T-CELL, ACUTE; LYMPHOCYTE ACTIVATION; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUROMONAB-CD3; PHOSPHORYLATION; POTASSIUM; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; SCHIFF BASES; SIGNAL TRANSDUCTION; SODIUM; TUMOR CELLS, CULTURED;

EID: 0031227975     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hedrick, S. M., and F. J. Eidelman. 1993. T lymphocyte antigen receptors. In Fundamental Immunology, 3rd Ed. W. Paul, ed. Raven Press, New York, p. 421.
2. Weiss, A. T lymphocyte activation. In Fundamental Immunology, 3rd Ed. W. Paul, ed. Raven Press, New York, p. 467.
3. Mondino, A., and M. K. Jenkins. 1994. Surface proteins involved in T cell costimulation. J. Leukocyte Biol. 55:805.
4. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
5. Bell, G. M., and J. B. Imboden. 1995. CD2 and the regulation of T cell anergy. J. Immunol. 155:2805.
6. + T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155:45.
7. Rhodes, J. 1989. Evidence for an intercellular covalent reaction essential in antigen-specific T cell activation. J. Immunol. 143:1482.
8. S. Gao, X-M., and J. Rhodes. 1990. An essential role for constitutive Schiff baseforming ligands in antigen presentation to murine T cell clones. J. Immunol. 144:2883.
9. Rhodes, J. 1990. E-rosettes provide an analogue for Schiff base formation in specific T cell activation. J. Immunol. 145:463.
10. Rhodes, J., B. Zheng, and M. R. Lifely. 1992. Inhibition of specific T cell activation by monosaccharides is through their reactivity as aldehydes. Immunology 75:629.
11. Zheng, B., S. Brett, J. P. Tite, M. R. Lifely, T. A. Brodie, and J. Rhodes. 1992. Galactose oxidation in the design of immunogenic vaccines. Science 256:1560.
12. Rhodes, J., H. Chen, S. R. Hall, J. E. Beesley, D. C. Jenkins, P. Collins, and B. Zheng. 1995. Therapeutic potentiation of the immune system by costimulatory Schiff base-forming drugs. Nature 377:71.